RFC
WST icon

Regions Financial Corp’s West Pharmaceutical WST Stock Holding History

Regions Financial Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Sell
4,639
-1,839
-28% -$562K 0.01% 402
2026
Q1 		$1.62M Sell
6,478
-2,675
-29% -$666K 0.01% 403
2025
Q4 		$2.52M Sell
9,153
-1,441
-14% -$394K 0.02% 338
2025
Q3 		$2.78M Sell
10,594
-352
-3% -$85.6K 0.02% 328
2025
Q2 		$2.39M Sell
10,946
-23
-0.2% -$4.92K 0.02% 352
2025
Q1 		$2.46M Buy
10,969
+2,548
+30% +$702K 0.02% 330
2024
Q4 		$2.76M Buy
8,421
+691
+9% +$217K 0.02% 310
2024
Q3 		$2.32M Buy
7,730
+3,167
+69% +$970K 0.02% 351
2024
Q2 		$1.5M Buy
4,563
+361
+9% +$128K 0.01% 411
2024
Q1 		$1.66M Buy
4,202
+3,436
+449% +$1.27M 0.01% 410
2023
Q4 		$270K Buy
+766
New +$271K ﹤0.01% 725
2023
Q3 		– Sell
-526
Closed -$201K – 850
2023
Q2 		$201K Buy
+526
New +$188K ﹤0.01% 789
2022
Q2 		– Sell
-665
Closed -$273K – 916
2022
Q1 		$273K Buy
665
+10
+2% +$3.92K ﹤0.01% 788
2021
Q4 		$307K Sell
655
-39
-6% -$16.8K ﹤0.01% 777
2021
Q3 		$295K Sell
694
-35
-5% -$14.8K ﹤0.01% 769
2021
Q2 		$262K Sell
729
-205
-22% -$67.7K ﹤0.01% 798
2021
Q1 		$263K Sell
934
-251
-21% -$71.8K ﹤0.01% 747
2020
Q4 		$335K Sell
1,185
-1,184
-50% -$332K ﹤0.01% 648
2020
Q3 		$651K Sell
2,369
-900
-28% -$238K 0.01% 488
2020
Q2 		$742K Buy
3,269
+399
+14% +$78.4K 0.01% 465
2020
Q1 		$437K Sell
2,870
-127
-4% -$19.5K 0.01% 519
2019
Q4 		$451K Sell
2,997
-52
-2% -$7.57K ﹤0.01% 556
2019
Q3 		$432K Sell
3,049
-111
-4% -$15.3K ﹤0.01% 555
2019
Q2 		$395K Sell
3,160
-84
-3% -$9.91K ﹤0.01% 585
2019
Q1 		$358K Buy
3,244
+4
+0.1% +$416 ﹤0.01% 607
2018
Q4 		$318K Buy
3,240
+94
+3% +$10.2K ﹤0.01% 623
2018
Q3 		$389K Buy
3,146
+397
+14% +$44.5K ﹤0.01% 631
2018
Q2 		$273K Sell
2,749
-716
-21% -$65.9K ﹤0.01% 731
2018
Q1 		$305K Sell
3,465
-533
-13% -$49.9K ﹤0.01% 709
2017
Q4 		$395K Sell
3,998
-97
-2% -$9.51K ﹤0.01% 665
2017
Q3 		$394K Buy
4,095
+11
+0.3% +$995 ﹤0.01% 689
2017
Q2 		$386K Buy
4,084
+131
+3% +$12K ﹤0.01% 717
2017
Q1 		$323K Sell
3,953
-215
-5% -$18K ﹤0.01% 741
2016
Q4 		$353K Buy
4,168
+330
+9% +$25.9K ﹤0.01% 730
2016
Q3 		$286K Sell
3,838
-42
-1% -$3.33K ﹤0.01% 781
2016
Q2 		$294K Sell
3,880
-1,032
-21% -$75.1K ﹤0.01% 750
2016
Q1 		$340K Sell
4,912
-866
-15% -$52.1K ﹤0.01% 718
2015
Q4 		$347K Buy
5,778
+99
+2% +$5.96K ﹤0.01% 702
2015
Q3 		$307K Sell
5,679
-13
-0.2% -$758 ﹤0.01% 752
2015
Q2 		$331K Buy
5,692
+12
+0.2% +$670 ﹤0.01% 745
2015
Q1 		$342K Buy
5,680
+201
+4% +$10.7K ﹤0.01% 726
2014
Q4 		$292K Buy
5,479
+680
+14% +$34K ﹤0.01% 770
2014
Q3 		$215K Buy
+4,799
New +$204K ﹤0.01% 1044

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Regions Financial Corp's WST Position: Q2 2026 in Review

Regions Financial Corp reduced its West Pharmaceutical (WST) stake by 28% in Q2 2026, selling an estimated $562K and leaving 4,639 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #402.

Regions Financial Corp first reported a position in WST in Q3 2014 and has held it in 43 quarters since. The position peaked at $2.78M in Q3 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Regions Financial Corp held 4,639 shares of West Pharmaceutical worth $1.67M as of Q2 2026.
  • Regions Financial Corp sold 1,839 West Pharmaceutical shares in Q2 2026, an estimated $562K.
  • West Pharmaceutical made up 0.01% of Regions Financial Corp's portfolio in Q2 2026, its #402 holding.
  • Regions Financial Corp first reported a position in West Pharmaceutical in Q3 2014 and has held it in 43 quarters since.
  • Regions Financial Corp's West Pharmaceutical position peaked at $2.78M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.